Mergers & Acquisitions - Santen Pharmaceuticals

Filter

Current filters:

Santen Pharmaceuticals

Popular Filters

Akorn gains rights to Betimol from Santen

10-01-2014

US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Santen Pharma progresses acquisition of Novagali, gaining 50.55% stake

13-10-2011

Japanese drugmaker Santen Pharmaceuticals (TYO: 4536) says it has completed its previously-announced…

Mergers & AcquisitionsNovagaliOphthalmicsPharmaceuticalSanten Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top